The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 23,306 | 685,863 | SH | SOLE | 685,863 | 0 | 0 | ||
| COLUCID PHARMACEUTICALS INC | COM | 19716T101 | 24,972 | 3,056,563 | SH | SOLE | 3,056,563 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 45,975 | 3,224,046 | SH | SOLE | 3,224,046 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 14,224 | 950,161 | SH | SOLE | 950,161 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS INC | COM | 40434H104 | 3,482 | 1,280,185 | SH | SOLE | 1,280,185 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 177,856 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM | 46187J205 | 10,249 | 1,075,448 | SH | SOLE | 1,075,448 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 11,269 | 1,410,417 | SH | SOLE | 1,410,417 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | COM | 62957M104 | 7,911 | 1,054,823 | SH | SOLE | 1,054,823 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 184,243 | 3,610,487 | SH | SOLE | 3,610,487 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 66,513 | 3,367,763 | SH | SOLE | 3,367,763 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 20,899 | 1,117,002 | SH | SOLE | 1,117,002 | 0 | 0 | ||
| TOBIRA THERAPEUTICS INC | COM | 88883P101 | 25,460 | 2,027,091 | SH | SOLE | 2,027,091 | 0 | 0 | ||
| TOKAI PHARMACEUTICALS INC | COM | 88907J107 | 711 | 128,993 | SH | SOLE | 128,993 | 0 | 0 | ||
| VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 230,941 | 2,155,100 | SH | SOLE | 2,155,100 | 0 | 0 | ||
| VANGUARD INTL EQUITY INDEX F | FTSE EUROPE ETF | 922042874 | 98,033 | 2,101,000 | SH | SOLE | 2,101,000 | 0 | 0 | ||
| WRIGHT MED GROUP N V | RIGHT 03/01/2019 | N96617126 | 5,824 | 4,622,032 | PRN | SOLE | 0 | 0 | 4,622,032 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 753 | 127,563 | SH | SOLE | 127,563 | 0 | 0 | ||